Evolv Technologies Holdings, Inc. — 2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022; filed March 24, 2023. This is an annual report, not a standalone fourth-quarter filing. Evolv sells AI-based weapons-screening systems and related subscriptions and services, primarily to venues and institutions. Its flagship Evolv Express deployments increased from 703 to 2,267 during 2022.
Key financial results
| Metric | 2022 | 2021 |
|---|---|---|
| Revenue | $55.2 million | $23.4 million |
| Gross profit (margin) | $1.7 million (3.1%) | $4.0 million (17.2%) |
| Operating loss | $102.6 million | $55.3 million |
| Net loss | $86.4 million | $10.9 million |
| Net loss per share, basic and diluted | $0.60 | $0.15 |
| Cash used in operating activities | $74.7 million | $56.8 million |
- Revenue grew 136%: product revenue rose 135% to $32.0 million, subscription revenue 125% to $17.6 million, and service revenue 188% to $5.6 million.
- Product revenue generated a $9.6 million gross loss, versus $1.4 million gross profit in 2021. Product gross margin fell to negative 30% from 10%, reflecting product and channel mix, customer marketing arrangements, shipping costs, and scrap inventory.
- Subscription gross margin improved to 57% from 42%; service gross margin was 22%, compared with negative 32% in 2021. Overall gross margin nevertheless declined sharply.
- Operating expenses rose 76% to $104.3 million, including research and development of $18.8 million, sales and marketing of $46.6 million, and general and administrative expense of $37.7 million. Stock-based compensation was $22.5 million.
- Cash and cash equivalents were $229.8 million at year-end; total assets were $348.1 million. Investing activities used $23.9 million, primarily for leased equipment and internal-use software.
- Debt was $29.7 million at year-end, including $10.0 million current and $19.7 million noncurrent. The December 2022 SVB facility was secured by substantially all assets except intellectual property, carried a variable rate (8.5% at year-end), and required monthly principal and interest payments.
Changes, outlook, and risks
- Two customers, both channel partners, accounted for 31.0% of 2022 revenue: Motorola Solutions 20.9% and Customer A 10.1%. Motorola represented 39.0% of year-end receivables.
- Management plans to lead with a “pure subscription” model in 2023, leasing equipment rather than selling it. In March 2023, it arranged for contract manufacturer Columbia Tech to license technology and sell hardware directly in cases where customers require a purchase; Evolv expects to retain the subscription relationship. Execution and revenue effects are uncertain.
- Management expects research and development and sales and marketing costs to rise in 2023; general and administrative expense is expected to remain relatively consistent. It said year-end cash and expected operating cash flows should cover operating expenses and capital spending for at least 12 months from the filing date, while noting possible need for additional capital.
- Quarterly revenue increased to $20.9 million in Q4 2022 from $16.5 million in Q3; Q4 gross profit was $0.1 million and net loss was $28.3 million. Quarterly results can vary with the timing of large deals.
- SVB was closed in March 2023; the filing says its deposits were transferred to the successor bridge bank and made available in full under government action, and that the bridge bank assumed Evolv’s loans. Evolv was reviewing deposit concentration. The filing warns that a failure at another institution could impair access to uninsured funds.
- Management reported ineffective disclosure controls and material weaknesses in financial reporting controls, including revenue timing, complex transactions, reconciliations, segregation of duties, and IT controls. Remediation was underway but not complete. Prior-period statements were revised for identified errors, which management deemed immaterial to previously issued statements; the revisions affected classifications and cash-flow presentation as well as some financial-statement amounts.
- Other material risks include dependence on a single contract manufacturer and some limited-source components, reseller reliance, product failure or missed threats, privacy and cybersecurity obligations, competition, and the uncertain adoption of a new market. The company remained loss-making, with an accumulated deficit of $192.2 million.
Most important facts for investors to verify
- Whether revenue growth converts into sustainable positive gross margins, especially given negative product margins in 2022.
- Cash burn, equipment investment needs, debt service and covenants, and actual liquidity following the SVB disruption and deposit-concentration review.
- Customer and reseller concentration, including Motorola’s share of revenue and receivables, and the durability of channel relationships.
- Progress and economics of the shift to pure subscriptions and Columbia Tech’s hardware-licensing arrangement.
- Whether internal-control material weaknesses are remediated and whether future reporting avoids further corrections or revisions.
- Whether customers renew and expand deployments, and whether Evolv’s systems perform reliably in real-world screening conditions.